Loading...
Loading...
MTRYW| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 369.1K |
| Gross Profit | -369.1K |
| Operating Expense | 369.1K |
| Operating I/L | -369.1K |
| Other Income/Expense | 11.7K |
| Interest Income | 11.7K |
| Pretax | -357.4K |
| Income Tax Expense | -11.7K |
| Net Income/Loss | -345.7K |
Monterey Bio Acquisition Corporation specializes in facilitating mergers, stock exchanges, asset acquisitions, and reorganizations with businesses in the biotech industry. By identifying and acquiring promising biotech companies, the corporation aims to create value through strategic business combinations. Formerly known as Chardan FinTech Acquisition Corp., the company rebranded as Monterey Bio Acquisition Corporation in April 2021, reflecting its focus on the biotech sector.
